Meridian Financial Partners’s Pfizer PFE Stock Holding History

Meridian Financial Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$810K	Sell	32,642 -834	-2%	-$21.8K	0.28%	62
2026 Q1	$907K	Buy	33,476 +876	+3%	+$23.3K	0.34%	59
2025 Q4	$844K	Sell	32,600 -469	-1%	-$11.8K	0.33%	58
2025 Q3	$849K	Buy	33,069 +627	+2%	+$15.5K	0.35%	58
2025 Q2	$786K	Buy	32,442 +1,916	+6%	+$44.7K	0.37%	57
2025 Q1	$774K	Buy	30,526 +2,743	+10%	+$71.8K	0.39%	55
2024 Q4	$737K	Sell	27,783 -4,785	-15%	-$130K	0.39%	55
2024 Q3	$943K	Sell	32,568 -255	-0.8%	-$7.44K	0.48%	49
2024 Q2	$975K	Buy	+32,823	New	+$904K	0.58%	45
2023 Q3	–	Sell	-29,374	Closed	-$1.08M	–	78
2023 Q2	$1.08M	Buy	+29,374	New	+$1.14M	0.65%	40
2022 Q3	–	Sell	-10,396	Closed	-$540K	–	74
2022 Q2	$540K	Buy	+10,396	New	+$530K	0.37%	55
2022 Q1	–	Sell	-10,541	Closed	-$564K	–	72
2021 Q4	$564K	Sell	10,541 -225	-2%	-$11.1K	0.38%	52
2021 Q3	$446K	Buy	10,766 +225	+2%	+$9.97K	0.3%	56
2021 Q2	$433K	Sell	10,541 -126	-1%	-$4.9K	0.3%	55
2021 Q1	$416K	Buy	10,667 +132	+1%	+$4.69K	0.31%	52
2020 Q4	$385K	Sell	10,535 -622	-6%	-$22.8K	0.3%	52
2020 Q3	$401K	Buy	11,157 +257	+2%	+$9.01K	0.34%	51
2020 Q2	$364K	Buy	+10,900	New	+$370K	0.33%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Meridian Financial Partners's PFE Position: Q2 2026 in Review

Meridian Financial Partners reduced its Pfizer (PFE) stake by 2.5% in Q2 2026, selling an estimated $21.8K and leaving 32,642 shares worth $810K. The position accounts for 0.28% of the portfolio, ranked #62.

Meridian Financial Partners first reported a position in PFE in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.08M in Q2 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Meridian Financial Partners held 32,642 shares of Pfizer worth $810K as of Q2 2026.
Meridian Financial Partners sold 834 Pfizer shares in Q2 2026, an estimated $21.8K.
Pfizer made up 0.28% of Meridian Financial Partners's portfolio in Q2 2026, its #62 holding.
Meridian Financial Partners first reported a position in Pfizer in Q2 2020 and has held it in 18 quarters since.
Meridian Financial Partners's Pfizer position peaked at $1.08M in Q2 2023.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Meridian Financial Partners's 13F filing for Q2 2026, filed 24 Jul 2026.